NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

BioLight Life Sciences Ltd (TA: BOLT)

 
BOLT Technical Analysis
4
As on 1st Sep 2025 BOLT STOCK Price closed @ 542.10 and we RECOMMEND Buy for LONG-TERM with Stoploss of 467.53 & Strong Buy for SHORT-TERM with Stoploss of 430.67 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BOLTSTOCK Price

Open 542.00 Change Price %
High 542.10 1 Day 12.10 2.28
Low 542.00 1 Week 12.80 2.42
Close 542.10 1 Month 49.50 10.05
Volume 260 1 Year 60.10 12.47
52 Week High 699.40 | 52 Week Low 338.40
 
TA Israel Most Active Stocks
TA125 2008.05 1.06%
ORL 82.30 -2.49%
BEZQ 609.20 -0.68%
RATI-L 443.50 -1.29%
MGDL 1126.00 -3.76%
POLI 6340.00 -1.17%
LUMI 6198.00 -1.57%
ELAL 1430.00 0.70%
DSCT 3145.00 -2.51%
KTOV 3.20 -8.57%
 
TA Israel Top Gainers Stocks
TDGN-L 171.50 17.55%
MCRNT 372.50 16.84%
CNMD 45.10 10.54%
CNMD 45.10 10.54%
HMAM 695.90 9.14%
SHAN 553.00 8.97%
SFET 65.10 8.50%
SFET 65.10 8.50%
EMTC 23.80 8.18%
HDST 55.00 7.84%
 
TA Israel Top Losers Stocks
KMNK 51.00 -23.19%
ULTR 74.10 -16.74%
MEAT 0.77 -9.41%
MEAT 0.77 -9.41%
BIRM 1026.00 -8.88%
PPBT 3.10 -8.82%
PPBT 3.10 -8.82%
MYSZ 153.90 -8.66%
MYSZ 153.90 -8.66%
AYAL 6600.00 -8.59%
 
 
BOLT
Daily Charts
BOLT
Intraday Charts
Whats New @
Bazaartrend
BOLT
Free Analysis
 
BOLT Important Levels Intraday
RESISTANCE542.29
RESISTANCE542.23
RESISTANCE542.19
RESISTANCE542.15
SUPPORT542.05
SUPPORT542.01
SUPPORT541.97
SUPPORT541.91
 
BOLT Forecast September 2025
4th UP Forecast852.35
3rd UP Forecast752.85
2nd UP Forecast691.35
1st UP Forecast629.85
1st DOWN Forecast454.36
2nd DOWN Forecast392.85
3rd DOWN Forecast331.35
4th DOWN Forecast231.85
 
BOLT Weekly Forecast
4th UP Forecast657.72
3rd UP Forecast620.64
2nd UP Forecast597.72
1st UP Forecast574.80
1st DOWN Forecast509.40
2nd DOWN Forecast486.48
3rd DOWN Forecast463.56
4th DOWN Forecast426.48
 
BOLT Forecast2025
4th UP Forecast1250.66
3rd UP Forecast1023.42
2nd UP Forecast882.96
1st UP Forecast742.5
1st DOWN Forecast341.7
2nd DOWN Forecast201.24
3rd DOWN Forecast60.78
4th DOWN Forecast-166.46
 
 
BOLT Other Details
Segment EQ
Market Capital 5583224320.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
BOLT Address
BOLT
 
BOLT Latest News
 
Your Comments and Response on BioLight Life Sciences Ltd
 
BOLT Business Profile
BioLight Life Sciences Ltd., an ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions comprising glaucoma, dry eye syndrome, and age-related macular degeneration. The company's ophthalmic product offering and pipeline of product candidates include IOPtiMate, a laser-based surgical treatment for glaucoma; TeaRx, a point-of-care multi-parameter diagnostic test for dry eye syndrome; Eye-D, a controlled release drug-delivery insert platform; OphRx, a non-invasive topical drug delivery technology; and LipiTear, a micro-emulsion technology for the dry eye treatment, as well as for the treatment of other ocular diseases. It also invests in cancer diagnostics technologies, including proprietary tests that are designated for bladder, cervical, multiple myeloma, and other cancers. The company was formerly known as Bio Light Israeli Life Sciences Investments Ltd. and changed its name to BioLight Life Sciences Ltd. in February 2016. BioLight Life Sciences Ltd. was founded in 2005 and is based in Tel Aviv, Israel. Address: Atidim Park Tel Aviv, Tel Aviv, Israel, 6158101
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service